The complement system covalently attaches C3d to microbial antigens wh
ich binds to CR2 on B lymphocytes, leading to a markedly enhanced adap
tive immune response to that antigen. The enhancement is mediated by t
he cross-linking of the CR2-CD19 complex to mIg which augments the act
ivation of several intracellular signalling pathways. Two additional r
eceptors of the B lymphocyte, Fc gamma RIIB and CD22, have opposing ef
fects when cross-linked to mIg, the former suppressing signalling by r
ecruiting the inositol phosphatase, SHIP, and the latter by activating
the phosphotyrosine phosphatase, SHP-1. Two principles emerge from th
ese studies: innate immunity guides the adaptive immune response, and
activation of the B lymphocyte is determined by co-receptors which eva
luate the biological characteristics of antigen.